Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092714
Filing Date
2024-08-07
Accepted
2024-08-07 16:00:27
Documents
65
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20240630.htm   iXBRL 10-Q 1737520
2 EX-31.1 enta-ex31_1.htm EX-31.1 10934
3 EX-31.2 enta-ex31_2.htm EX-31.2 10944
4 EX-32.1 enta-ex32_1.htm EX-32.1 10396
5 GRAPHIC img216962810_0.jpg GRAPHIC 645173
  Complete submission text file 0000950170-24-092714.txt   8568161

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT enta-20240630.xsd EX-101.SCH 986826
68 EXTRACTED XBRL INSTANCE DOCUMENT enta-20240630_htm.xml XML 1312725
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 241183436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)